Our innovative technology targets cancer cells using tumor-targeting dye technology—specific dyes that deliver chemotherapy directly to cancer cells, sparing healthy tissues. The treatment is activated only within the specific cancer cell environment, minimizing side effects and boosting efficacy.

With the ability to target over 30 cancer types, including the potential to treat metastatic tumors, and backed by strong pre-clinical data, we believe that one day, we may be able to significantly improve outcomes for patients.